EXACT SCIENCES CORP: Exact Sciences Demonstrates Power of Multi-Cancer Early Detection Approach with Data Presentation at the 2022 European Society for Medical Oncology Congress

Multi-Biomarker Approach Achieves 61 Percent Sensitivity for Cancer at an Overall Specificity of 98.2 Percent in Robust Case-Control Study Including Nearly 600 Cancer Samples Data will

Related Keywords

United States ,Canada ,America ,American ,Jack Hirschfield ,Anne Marie Lennon ,Johns Hopkins ,Tom Beer ,Federico Maiardi ,Megan Jones ,Sciences Corp ,Sciences On Facebook ,Division Of Gastroenterology ,World Health Organization ,Sciences On Twitter Exactsciences ,Nasdaq ,Prnewswire Exact Sciences Corp ,Exchange Commission ,European Society For Medical Oncology ,American Cancer Society ,Multi Biomarker Approach Achieves ,Overall Specificity ,Robust Case Control Study Including Nearly ,Exact Science Screening ,European Society ,Medical Oncology ,Mayo Clinic ,Cancer Stage ,Four Biomarker Class ,Study Of All ,Exact Sciences ,Risk Factors ,Exact Science ,Annual Report ,Quarterly Reports ,Latin America ,Global Facts ,Exact ,Ciences ,Orp ,Emonstrates ,Tower ,Ulti ,Dancer ,Early ,Detection ,Approach ,Data ,Presentation ,022 ,European ,Society ,Medical ,Ncology ,Congress ,